This brand name is authorized in Nigeria.
The drug STOMPROZOL contains one active pharmaceutical ingredient (API):
1
|
UNII
80061L1WGD - CIMETIDINE
|
|
Cimetidine is a histamine H2-receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. It is a reversible, competitive antagonist, and is used as an anti-ulcer drug. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-8843 | Tablet | STOMPROZOL 400 TABLET TAB 400 mg 10X10,10x20 | STOMPROZOL 400 TABLET CIMETIDINE 400MG CIMETIDINE 400MG, cornstarch 46.36mg dextrin 16.10mg sucrose 16.10mg Carboxymethyl Starch Sodium 17.10mg 6 0% ethanol 102.16mg 2% hypromellose 55.40mg Magnesium stearate 9.44mg Carboxymethyl Starch Sodium 21.80mg B4-8843 Drugs Imported Products 10X10,10x20 Prescription Only Medicine (POM) 08/06/2023 APHANTEE PHARM NIGERIA LTD, SUITE FF 11, PACIFIC COMPLEX AWKA ROAD ONITSHA ANAMBRA 8077261675 aphanteepharm@yahoo.com JIANGSU RUINIAN QIANJIN PHARMACEUTICAL CO., LIMITED, CHUANBU VILLAGE, YIXING ECONOMIC DEVELOPMENT ZONE, JIANGSU PROVINCE, CHINA., China | 31/08/2023 |
| B4-8844 | Tablet | STOMPROZOL 200 TABLET TAB 200 mg 10X10,10x20 | STOMPROZOL 200 TABLET CIMETIDINE 200MG CIMETIDINE 200mg, cornstarch 23.18mg dextrin 8.05mg sucrose 8.05mg Carboxymethyl Starch Sodium 8.55mg 6 0% ethanol 51.08mg 2% hypromellose 27.70mg Magnesium stearate 4.72mg Carboxymethyl Starch Sodium 10.90mg B4-8844 Drugs Imported Products 10X10,10x20 Prescription Only Medicine (POM) 08/06/2023 APHANTEE PHARM NIGERIA LTD, SUITE FF 11, PACIFIC COMPLEX AWKA ROAD ONITSHA ANAMBRA 8077261675 aphanteepharm@yahoo.com JIANGSU RUINIAN QIANJIN PHARMACEUTICAL CO., LTD, CHUANBU VILLAGE, DINGSHU TOWN, YIXING CITY, JIANGSU PROVINCE, CHINA., China | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A02BA01 | Cimetidine | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BA H2-receptor antagonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-8843, B4-8844 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.